{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:07:14Z","timestamp":1784552834911,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00192-026-06518-6","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:57:07Z","timestamp":1770987427000},"page":"2163-2170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PANTHERA \u201cPelvic Floor Disorders in Patients Under ANtineoplastic THERApy\u201d Prospective Evaluation of Subjectively Perceived Pelvic Floor Function in Patients with Gynecologic and Breast Cancers Undergoing Systemic Antineoplastic Therapy Using a Validated Pelvic Floor Questionnaire"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8015-5973","authenticated-orcid":false,"given":"Bettina","family":"Blau-Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"B\u00fcchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kiesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Bartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"W\u00f6ckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"6518_CR1","doi-asserted-by":"publisher","DOI":"10.17886\/rkipubl-2016-014","volume-title":"Bericht zum Krebsgeschehen in Deutschland 2016","author":"B Barnes","year":"2016","unstructured":"Barnes B, Kraywinkel K, Nowossadeck E, Sch\u00f6nfeld I, Starker A, Wienecke A, et al. Bericht zum Krebsgeschehen in Deutschland 2016. Berlin: Robert Koch-Institut; 2016. https:\/\/doi.org\/10.17886\/rkipubl-2016-014."},{"issue":"2","key":"6518_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ygyno.2015.11.010","volume":"140","author":"LB Huffman","year":"2016","unstructured":"Huffman LB, Hartenbach EM, Carter J, Rash JK, Kushner DM. Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide. Gynecol Oncol. 2016;140(2):359\u201368. https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.010.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"6518_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00192-017-3467-4","volume":"29","author":"AS Ramaseshan","year":"2018","unstructured":"Ramaseshan AS, Felton J, Roque D, Rao G, Shipper AG, Sanses TVD. Pelvic floor disorders in women with gynecologic malignancies: a systematic review. Int Urogynecol J. 2018;29(4):459\u201376. https:\/\/doi.org\/10.1007\/s00192-017-3467-4.","journal-title":"Int Urogynecol J"},{"issue":"9","key":"6518_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa2308900","volume":"390","author":"M Plante","year":"2024","unstructured":"Plante M, Kwon JS, Ferguson S, Samou\u00eblian V, Ferron G, Maulard A, et al. Simple versus radical hysterectomy in women with low-risk cervical cancer. N Engl J Med. 2024;390(9):819\u201329. https:\/\/doi.org\/10.1056\/NEJMoa2308900.","journal-title":"N Engl J Med"},{"issue":"8","key":"6518_CR5","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1097\/IGC.0000000000000776","volume":"26","author":"M Derks","year":"2016","unstructured":"Derks M, van der Velden J, Frijstein MM, Vermeer WM, Stiggelbout AM, Roovers JP, et al. Long-term pelvic floor function and quality of life after radical surgery for cervical cancer: a multicenter comparison between different techniques for radical hysterectomy with pelvic lymphadenectomy. Int J Gynecol Cancer. 2016;26(8):1538\u201343. https:\/\/doi.org\/10.1097\/IGC.0000000000000776.","journal-title":"Int J Gynecol Cancer"},{"issue":"18","key":"6518_CR6","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJM199905063401802","volume":"340","author":"K Bergmark","year":"1999","unstructured":"Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med. 1999;340(18):1383\u20139. https:\/\/doi.org\/10.1056\/NEJM199905063401802.","journal-title":"N Engl J Med"},{"issue":"5","key":"6518_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/annonc\/mdp394","volume":"21","author":"HG Mar Fan","year":"2010","unstructured":"Mar Fan HG, Hou\u00e9d\u00e9-Tchen N, Chemerynsky I, Yi QL, Xu W, Harvey B, et al. Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study. Ann Oncol. 2010;21(5):983\u20137. https:\/\/doi.org\/10.1093\/annonc\/mdp394.","journal-title":"Ann Oncol"},{"issue":"7","key":"6518_CR8","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S1470-2045(15)00049-2","volume":"16","author":"J Bernhard","year":"2015","unstructured":"Bernhard J, Luo W, Ribi K, Colleoni M, Burstein HJ, Tondini C, et al. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. Lancet Oncol. 2015;16(7):848\u201358. https:\/\/doi.org\/10.1016\/S1470-2045(15)00049-2.","journal-title":"Lancet Oncol"},{"issue":"2","key":"6518_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3816\/CBC.2009.n.020","volume":"9","author":"SN Chin","year":"2009","unstructured":"Chin SN, Trinkaus M, Simmons C, Flynn C, Dranitsaris G, Bolivar R, et al. Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer. Clin Breast Cancer. 2009;9(2):108\u201317. https:\/\/doi.org\/10.3816\/CBC.2009.n.020.","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"6518_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1200\/JCO.1998.16.2.501","volume":"16","author":"PA Ganz","year":"1998","unstructured":"Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women\u2019s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16(2):501\u201314. https:\/\/doi.org\/10.1200\/JCO.1998.16.2.501.","journal-title":"J Clin Oncol"},{"issue":"3","key":"6518_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/AOG.0b013e318227b7ac","volume":"118","author":"RM T\u00e4htinen","year":"2011","unstructured":"T\u00e4htinen RM, Auvinen A, Cartwright R, Johnson TM 2nd, Tammela TLJ, Tikkinen KAO. Smoking and bladder symptoms in women. Obstet Gynecol. 2011;118(3):643\u20138. https:\/\/doi.org\/10.1097\/AOG.0b013e318227b7ac.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"6518_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/01.ju.0000162056.30326.83","volume":"174","author":"LL Subak","year":"2005","unstructured":"Subak LL, Whitcomb E, Shen H, Saxton J, Vittinghoff E, Brown JS. Weight loss: a novel and effective treatment for urinary incontinence. Weight loss: a novel and effective treatment for urinary incontinence. J Urol. 2005;174(1):190\u20135. https:\/\/doi.org\/10.1097\/01.ju.0000162056.30326.83.","journal-title":"J Urol"},{"issue":"9","key":"6518_CR13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00192-016-2962-3","volume":"27","author":"CE Bretschneider","year":"2016","unstructured":"Bretschneider CE, Doll KM, Bensen JT, Gehrig PA, Wu JM, Geller EJ. Prevalence of pelvic floor disorders in women with suspected gynecological malignancy: a survey-based study. Int Urogynecol J. 2016;27(9):1409\u201314. https:\/\/doi.org\/10.1007\/s00192-016-2962-3.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"6518_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.eururo.2011.07.049","volume":"61","author":"KS Coyne","year":"2012","unstructured":"Coyne KS, Kvasz M, Ireland AM, Milsom I, Kopp ZS, Chapple CR. Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol. 2012;61(1):88\u201395. https:\/\/doi.org\/10.1016\/j.eururo.2011.07.049.","journal-title":"Eur Urol"},{"issue":"1","key":"6518_CR15","doi-asserted-by":"publisher","first-page":"E39","DOI":"10.1097\/NCC.0000000000000251","volume":"39","author":"CL Paterson","year":"2016","unstructured":"Paterson CL, Lengacher CA, Donovan KA, Kip KE, Tofthagen CS. Body image in younger breast cancer survivors: a systematic review. Cancer Nurs. 2016;39(1):E39-58. https:\/\/doi.org\/10.1097\/NCC.0000000000000251.","journal-title":"Cancer Nurs"},{"issue":"1","key":"6518_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/gyno.2000.5745","volume":"77","author":"MS Green","year":"2000","unstructured":"Green MS, Naumann RW, Elliot M, Hall JB, Higgins RV, Grigsby JH. Sexual dysfunction following vulvectomy. Gynecol Oncol. 2000;77(1):73\u20137. https:\/\/doi.org\/10.1006\/gyno.2000.5745.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"6518_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ajog.2017.04.012","volume":"217","author":"M Whicker","year":"2017","unstructured":"Whicker M, Black J, Altwerger G, Menderes G, Feinberg J, Ratner E. Management of sexuality, intimacy, and menopause symptoms in patients with ovarian cancer. Am J Obstet Gynecol. 2017;217(4):395\u2013403. https:\/\/doi.org\/10.1016\/j.ajog.2017.04.012.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"6518_CR18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5694\/j.1326-5377.2007.tb00877.x","volume":"5","author":"AJ Hordern","year":"2007","unstructured":"Hordern AJ, Street AF. Communicating about patient sexuality and intimacy after cancer: mismatched expectations and unmet needs. Med J Aust. 2007;5(5):224\u20137. https:\/\/doi.org\/10.5694\/j.1326-5377.2007.tb00877.x.","journal-title":"Med J Aust"},{"issue":"6","key":"6518_CR19","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/j.jmwh.2006.06.004","volume":"51","author":"LH Koch","year":"2006","unstructured":"Koch LH. Help-seeking behaviors of women with urinary incontinence: an integrative literature review. J Midwifery Womens Health. 2006;51(6):e39-44. https:\/\/doi.org\/10.1016\/j.jmwh.2006.06.004.","journal-title":"J Midwifery Womens Health"},{"issue":"4","key":"6518_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000301098","volume":"49","author":"K Baessler","year":"2009","unstructured":"Baessler K, Kempkensteffen C. Validierung eines umfassenden Beckenboden-Fragebogens f\u00fcr Klinik, Praxis und Forschung [Validation of a comprehensive pelvic floor questionnaire for the hospital, private practice and research]. Gynakol Geburtshilfliche Rundsch. 2009;49(4):299\u2013307. https:\/\/doi.org\/10.1159\/000301098.","journal-title":"Gynakol Geburtshilfliche Rundsch"},{"issue":"5","key":"6518_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1055\/s-0031-1271544","volume":"42","author":"K Baessler","year":"2011","unstructured":"Baessler K, Junginger B. Beckenboden-Fragebogen f\u00fcr Frauen. Validierung eines Instrumentes mit posttherapeutischem Modul zur Evaluation von Symptomen, Leidensdruck, Lebensqualit\u00e4t, Verbesserung und Zufriedenheit [Validation of a pelvic floor questionnaire with improvement and satisfaction scales to assess symptom severity, bothersomeness and quality of life before and after pelvic floor therapy]. Aktuelle Urol. 2011;42(5):316\u201322. https:\/\/doi.org\/10.1055\/s-0031-1271544.","journal-title":"Aktuelle Urol"},{"issue":"2","key":"6518_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ijgo.15719","volume":"167","author":"RA Peinado Molina","year":"2024","unstructured":"Peinado Molina RA, Mart\u00ednez V\u00e1zquez S, Mart\u00ednez Galiano JM, Rivera Izquierdo M, Khan KS, Cano-Ib\u00e1\u00f1ez N. Prevalence of depression and anxiety in women with pelvic floor dysfunctions: a systematic review and meta-analysis. Int J Gynaecol Obstet. 2024;167(2):507\u201328. https:\/\/doi.org\/10.1002\/ijgo.15719.","journal-title":"Int J Gynaecol Obstet"},{"issue":"7","key":"6518_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2165\/00002512-200825070-00001","volume":"25","author":"P Tsakiris","year":"2008","unstructured":"Tsakiris P, Oelke M, Michel MC. Drug-induced urinary incontinence. Drugs Aging. 2008;25(7):541\u20139. https:\/\/doi.org\/10.2165\/00002512-200825070-00001.","journal-title":"Drugs Aging"},{"issue":"6","key":"6518_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.6004\/jnccn.2020.7535","volume":"18","author":"CP Chung","year":"2020","unstructured":"Chung CP, Behrendt C, Wong L, Flores S, Mortimer JE. Serial assessment of urinary incontinence in breast cancer survivors undergoing (neo)adjuvant therapy. J Natl Compr Canc Netw. 2020;18(6):712\u20136. https:\/\/doi.org\/10.6004\/jnccn.2020.7535.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"6518_CR25","doi-asserted-by":"publisher","first-page":"514.e1","DOI":"10.1016\/j.ajog.2010.08.004","volume":"203","author":"TL Rutledge","year":"2010","unstructured":"Rutledge TL, Heckman SR, Qualls C, Muller CY, Rogers RG. Pelvic floor disorders and sexual function in gynecologic cancer survivors: a cohort study. Am J Obstet Gynecol. 2010;203(5):514.e1-7. https:\/\/doi.org\/10.1016\/j.ajog.2010.08.004.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"6518_CR26","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/ijgc-2020-001529","volume":"30","author":"CJ Strauchon","year":"2020","unstructured":"Strauchon CJ, Dengler KL, Gruber DD, Katebi Kashi P, Aungst MJ, Trikhacheva A, et al. Urinary symptoms in women receiving carboplatin\/paclitaxel for treatment of gynecologic cancers. Int J Gynecol Cancer. 2020;30(9):1418\u201323. https:\/\/doi.org\/10.1136\/ijgc-2020-001529.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"6518_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/IGC.0b013e3181d373bf","volume":"20","author":"G Dunberger","year":"2010","unstructured":"Dunberger G, Lind H, Steineck G, Waldenstr\u00f6m AC, Nyberg T, al-Abany M, et al. Fecal incontinence affecting quality of life and social functioning among long-term gynecological cancer survivors. Int J Gynecol Cancer. 2010;20(3):449\u201360. https:\/\/doi.org\/10.1111\/IGC.0b013e3181d373bf.","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"6518_CR28","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1136\/ijgc-2020-001551","volume":"30","author":"A Hasenburg","year":"2020","unstructured":"Hasenburg A, Sehouli J, Lampe B, Reuss A, Schmalfeld B, Belau AK, et al. LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial. Int J Gynecol Cancer. 2020;30(10):1548\u201353. https:\/\/doi.org\/10.1136\/ijgc-2020-001551.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"6518_CR29","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/AOG.0b013e3182a7ef3c","volume":"122","author":"SG Thomas","year":"2013","unstructured":"Thomas SG, Sato HRN, Glantz JC, Doyle PJ, Buchsbaum GM. Prevalence of symptomatic pelvic floor disorders among gynecologic oncology patients. Obstet Gynecol. 2013;122(5):976\u201380. https:\/\/doi.org\/10.1097\/AOG.0b013e3182a7ef3c.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"6518_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092804","volume":"9","author":"A Zi\u0119tek-Strobl","year":"2020","unstructured":"Zi\u0119tek-Strobl A, Futyma K, Kuna-Broniowska I, Wojta\u015b M, Rechberger T. Urogynaecological symptoms among oncological survivors and impact of oncological treatment on pelvic floor disorders and lower urinary tract symptoms. A six-month follow-up study. J Clin Med. 2020;9(9):2804. https:\/\/doi.org\/10.3390\/jcm9092804.","journal-title":"J Clin Med"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06518-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-026-06518-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06518-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:52:23Z","timestamp":1784551943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-026-06518-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["6518"],"URL":"https:\/\/doi.org\/10.1007\/s00192-026-06518-6","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has received ethical approval (approval number FF 98\/2017) from the Ethics Committee of the State Medical Chamber of Hesse.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B.B.-S.: honoria and expenses from INTUITIVE Surgical, PFM Medical, MSD, Seagen, none of them related to this trial. A.L.: honoria from AstraZeneca, Novartis, Roche, consulting fees from Daiichi Sankyo, GSK, none of them related to this trial. J.B.: no conflicts of interest. M.K.: no conflicts of interest. A.B.: no conflicts of interest. A.W.: consulting fees from Amgen, AstraZeneca, Celgene, Lilly, Novartis, Pfizer, Roche, MSD, Genomic Health, Organon, Seagen, Gilead, Dajiichi Sanko, Stemline, none of them related to this trial; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca, Aurikamed, Celgene, Lilly, Novartis, Pfizer, Roche, MSD, Genomic Health, Seagen, Exact Sciences, Gilead, Dajiichi Sanko, Onkowissen, Stemline, none of them related to this trial. B.G.: honoria and expenses from INTUITIVE Surgical, Serag-Wiessner, Member of the German incontinence and POP guidelines group, none of them related to this trial.","order":2,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}